Valirx Share Discussion Threads

[nico115] 16/11/2021 12:08

So sorry for your losses in PycStick to quality Stig then you won't need to ramp Pyc on hundreds of other threads !! Lol

[the stigologist] 16/11/2021 10:25

When you have con pump and dump scum like that nonce cos-playing as a children's cartoon pig and snake Nick Slater involved you have to watch your back

They'll talk the stock up one day and be selling behind your back the next

[the stigologist] 16/11/2021 08:16

Good grief. Guy can't even speak English.

[nico115] 16/11/2021 01:46

Your making a fool out of yourself No one here is interested in PYCIt's unchanged for 2 years We are up 600pct as Val share holders You are a good ramper You must be so desperate to sellYour PYC holding to buy Val Sorry for your pyc losses Awful in a raging bull market

[the stigologist] 15/11/2021 23:10

Very funny to see people make fools of themselves

Physiomics PYC just published their Annual Report and Accounts a few weeks ago

At financial year end in June 2021 they had Cash of over 1,000,000

In the last financial year the net cash outflow was only 30,000

i.e. they have over 30 years of cash 'runway'

[jasonpugh] 15/11/2021 22:49

End of 2023 for full payments from assessment to valirx for 201. If you have invested and your time preference rates cannot be bettered then put investment in the draw to synergise with suzys 3 year plan..long term investment

[nico115] 15/11/2021 20:47

Totally agree I would sell pyc down to 2pIt's a pile of pooStig stuck and can't move Shame : )

[jayj4u] 15/11/2021 20:44

PYC has placing coming... they spent 9 months working for VAL for FREE. VAL has money in the Bank but what does PYC have...f@@k ALL! Just big wages to pay out. It will hurt them short term. VAL used them and got them to test out 3 of their drugs for $60,000. Suzy is just too smart for PYC.

Would I buy PYC on BS theories? No chance!

[nico115] 15/11/2021 18:25

If I followed Stig I would be bust now I like to do the opposite

[vanduke] 15/11/2021 17:31

I believe Stig has a 1000 pounds target on 4D by 2025;-)

[francoismyname] 14/11/2021 23:29

I would not be surprised if a fund raise happened here.

Val has form for it.

[nico115] 14/11/2021 16:43

I've held most of my holdings for years You are obviously desperate to pump and dumpPyc by posting on other threads 30k posts by yourself sums up how long you hold sticks for !! Hahahahaha

[the stigologist] 14/11/2021 16:16

Of course a pump and dumper thinks everyone else has the same negative traits as themselves. I think most VAL investors understand connection between PYC and VAL and importance of Modelling and Simulation software

[nico115] 14/11/2021 16:12

Desperate to sell Pyc are you ?!!Why else ramp Pyc on Val and Sar??!!Buy Val and sell Pyc a great pairs trade Pyc looks overvalued to me Wouldn't touch it with a barge pole

[the stigologist] 14/11/2021 14:42

Physiomics PYC in July talking about the FDA's 'Project Optimus' a major FDA project focused on Precision Dosing.

Physiomics have said previously they are getting exposure to Regulators via some of their client engagements

What would happen to PYC valuation if they announced a tie-up with the FDA ?!

PYC Mkt Cap of 7m is ridiculous given a client list including likes of Merck, Astellas, Bicycle Therapeutics, Numab, CellCentric etc either Big Pharma or leading edge First-in-Class or Best-in-Class emerging biotechs

[nico115] 13/11/2021 01:38

Didums stuck in a pile of poo called pyc So has to ramp it on sar and Val both of which have gone up fivefold I'm laughing my head off lolHahahahaha Sorry for your losses Stig

[the stigologist] 12/11/2021 22:57

I must admit it's a very disappointing deal given the sort of deals other similar stage small bio Companies have been able to extract

Fail on at least 3 fronts

1. Size of upfront - very poor (I expected $5-10m upfront)
2. Timing (the revenues are back end loaded even the supposed 'upfront' is a 2023 event)
3. Quality of partner (never heard of them, not a Big name Pharma or even Best/First in Class Bio)

The whole point of licensing tech out is so a bigger (balance sheet, human resources) more experienced, more specialist player can VALIDATE your IP, and leverage it into commerciality quicker by using their resources to overcome regulatory and commercial barriers. Signing a deal with a no name company with no balance sheet is a bad deal no matter how people spin it

Snake nick slater will start dumping soon so watch your backs

[ragnarr] 12/11/2021 21:49

Im not convinced that comment is that great - you let a lot of of people down.

[francoismyname] 12/11/2021 20:14

I’m not convinced the deal is that great. Suzy let a lot of people down

[the stigologist] 12/11/2021 14:37

PYC Physiomics

RNS today confirming they are presenting alongside BCYC Bicycle on Bicycle's BT7480

PYC Mkt Cap : £6m
BCYC Mkt Cap : $1600m

Physiomics helped them with the Modelling and Simulation of BT7480

This presentation at a major Global Cancer Conference is going to be great marketing for PYC who just recently took on ,for the first time, a dedicated Business Development Director from FAB Fusion Antibodies

This isn't even the real transformational part of the business which is going to be when they use their expertise in Modelling and Simulation gained thru consulting work for leading edge bios and Pharmas and put together dosing apps which can be used in NHS/US clinical use and where they then have potential for software IP licensing type deals

Chart looks ready to break out from a long and large pennant formation. Just popping its head above 200 day Moving Average as well today.






Bicycle regard themselves as 'well positioned to be the next generation of targeted oncology therapeutics' which places them in multi-billion blockbuster drug territory of antibodies and antibody-drug-conjugates !

Given their IP is based on Nobel prize winning science and they have partners like Roche Genentech and AstraZeneca its a great Company for PYC Physiomics to ride the coat-tails of

[1savvyinvestor] 12/11/2021 11:31

Volume pretty much dried up . Let's hope it settles around this level to set a strong base for the next stage up

[hedgehog 100] 11/11/2021 18:21

GENinCode (GENI), 38p, market cap. £36.41M.

22/07/2021 06:00 UK Regulatory (RNS & others) GENinCode PLC Admission to trading on AIM & First Day of Dealing LSE:GENI Genincode Plc
" ... The Company was incorporated in September 2018 to acquire the assets, intellectual property and know-how of the Ferrer inCode and Gendiag.exe businesses, which were then part of Grupo Ferrer Internacional S.A., a large Spanish multinational private pharmaceutical and healthcare company. The technology and products acquired included Cardio inCode®, Lipid inCode®, Thrombo inCode® and Sudd inCode®. The Directors believe that approximately €50 million has been invested in the research and development of these products since 2007. The Company has begun to commercialise these products in certain European countries and is also targeting the UK and US. ..."


€50 million equates to about £43M. at the current exchange rate.

Compared to GENI's current market cap. at 38p of £36.4M.
With GENI cash reserves post admission at 31 July 2021 of £16.7M.

Moreover, the sums invested have resulted in great products that are now being commercialised, so should actually be worth more.


diversification 6 Nov '21 - 17:39 - 20 of 24 0 2 0
"News must now be imminent as the November window closes and we should see both a winter rally in the broader markets and a deluge of news from Genincode. Time to be excited."



GENinCode (GENI):

[goldie40] 11/11/2021 08:52

two up coming presentations and q and a sessions must be positive for the share price